Kevzara Injection, Solution
Product Images NDC 0024-5908

Product Visual Gallery

This gallery contains 53 technical images submitted to the FDA as part of the official labeling for Kevzara (NDC 0024-5908). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sanofi-aventis U.s. Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Kevzara 01)

This is a graph showing the percentage of patients with ACR20 response over the course of a 24-week study. The study involved three groups: a placebo group with methotrexate (MTX), a group taking Kevzara 150 mg with MTX, and a group taking Kevzara 200 mg with MTX. The ACR20 response is measured numerically on the y-axis, and the weeks of the study are plotted on the x-axis.*

FDA Label Image

Image (Kevzara 01a)

FDA Label Image

Image (Kevzara 01b)

FDA Label Image

Image (Kevzara 01c)

FDA Label Image

Image (Kevzara 01d)

FDA Label Image

Image (Kevzara 01e)

FDA Label Image

Image (Kevzara 01f)

FDA Label Image

Image (Kevzara 01g)

FDA Label Image

Image (Kevzara 01h)

FDA Label Image

Image (Kevzara 01i)

FDA Label Image

Image (Kevzara 01j)

FDA Label Image

Image (Kevzara 01k)

FDA Label Image

Image (Kevzara 01m)

FDA Label Image

Image (Kevzara 01n)

FDA Label Image

Image (Kevzara 01o)

FDA Label Image

Image (Kevzara 01p)

FDA Label Image

Image (Kevzara 01q)

FDA Label Image

Image (Kevzara 01r)

FDA Label Image

Image (Kevzara 01s)

FDA Label Image

Image (Kevzara 01t)

FDA Label Image

Image (Kevzara 01u)

FDA Label Image

Image (Kevzara 01v)

FDA Label Image

Image (Kevzara 01w)

FDA Label Image

Image (Kevzara 01x)

FDA Label Image

Image (Kevzara 01y)

FDA Label Image

Image (Kevzara 02)

This text contains information about a medication called "KEVZARA®" (sarilumah), which is an injection with a dosage of 150 mg/114 my. The label also mentions a yellow needle cover and an orange cap. There is no other useful information provided in this text.*

FDA Label Image

Image (Kevzara 03)

This is a description of a prescription drug named KEVZARA®. It is administered via subcutaneous injection using a single-dose prefilled pen that contains 150 mg/1:14 my of the drug. The National Drug Code (NDC) for this medication is 0024.5920.0.*

FDA Label Image

Image (Kevzara 04)

FDA Label Image

Image (Kevzara 05)

FDA Label Image

Image (Kevzara 06)

FDA Label Image

Image (Kevzara 07)

FDA Label Image

Image (Kevzara 08)

FDA Label Image

Image (Kevzara 09)

FDA Label Image

Image (Kevzara 10)

FDA Label Image

Image (Kevzara 11)

FDA Label Image

Image (Kevzara 12)

FDA Label Image

Image (Kevzara 13)

FDA Label Image

Image (Kevzara 14)

FDA Label Image

Image (Kevzara 15)

This is a pre-filled pen containing 200mg of medicine and has a stated dosage of 114. It is meant for single use only and is administered via subcutaneous injection.*

FDA Label Image

Image (Kevzara 16)

FDA Label Image

Image (Kevzara 17)

FDA Label Image

Image (Kevzara 18)

FDA Label Image

Image (Kevzara 19)

FDA Label Image

Image (Kevzara 20)

FDA Label Image

Image (Kevzara 21)

FDA Label Image

Image (Kevzara 22)

FDA Label Image

Image (Kevzara 23)

FDA Label Image

Image (Kevzara 24)

FDA Label Image

Image (Kevzara 25)

FDA Label Image

Principal Display Panel (150 mg/1.14 mL Syringe Carton)

KEVZARA- is a medication that comes as 150 mg/1.14 mL (131.6 mg/mL) injection in 2 single-dose pre-filled syringes designed for subcutaneous use only. The package contains a package insert, medication guide, and instructions for use. Sarilumab is the active ingredient, and each pre-filled syringe holds 114 mL of solution containing 150 mg of it. Other ingredients include arginine, histidine, polysorbate 20, glucose, and sterile water or injection without preservatives. There is no US standard of potency. KEVZARA should be stored in the original carton in a refrigerator at 36°F to 46°F (2°C to 8°C) and should be protected from light. If needed, it can be stored at room temperature up to 77°F (25°C) up to 14 days in the outer carton, but no longer. The enclosed medication guide is required for each patient. More information about dosage and administration can be found in the package insert.*

FDA Label Image

Principal Display Panel (200 mg/1.14 mL Syringe Carton)

This is a description of a medicine packaging containing two single-dose pre-filled syringes, each containing 1.14mL of solution that delivers 200mg of Sarilumab. It includes a medication guide, instructions for use, and dosage information. The solution is sterile and has no preservatives, and it should be stored in a refrigerator at 36°F to 46°F in its original carton to protect it from light. The package insert should be followed, and any unused portion should be discarded in accordance with local requirements. The medicine is for subcutaneous injection use only.*

FDA Label Image

Principal Display Panel (150 mg/1.14 mL Pen Carton)

KEVZARA (sarilumab) is a medication provided in single-dose pre-filled pens for subcutaneous injection and is used to treat certain autoimmune diseases. Each pen contains 150mg of sarilumab, a solution of arginine, histidine, polysorbate, sucrose and water for injection. Each pen delivers a 50mg dose of the solution. The medication must be refrigerated at 36-46°F and protected from light. The discarded medication must be handled according to guidelines. The package contains dosing information and instructions for use. A medication guide is enclosed for each patient.*

FDA Label Image

Principal Display Panel (200 mg/1.14 mL Pen Carton)

This is a medication called KEVZARA (sarilumab) which is available in a pre-filled injection pen. It is used for subcutaneous injection and should be stored in a refrigerator at 36°F to 46°F. Dosage information and instructions for use can be found on the package insert. The medication is manufactured by Regeneron, Sanofi Genzyme.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.